Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) is -24.09% lower on its value in year-to-date trading and has touched a low of $13.51 and a high of $23.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MDRX stock was last observed hovering at around $13.72 in the last trading session, with the day’s loss setting it -0.33% off its average median price target of $18.50 for the next 12 months. It is also 48.5% off the consensus price target high of $26.00 offered by 8 analysts, but current levels are 21.24% higher than the price target low of $17.00 for the same period.
Currently trading at $13.39, the stock is -14.88% and -21.35% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.14 million and changing -2.41% at the moment leaves the stock -19.13% off its SMA200. MDRX registered -38.01% loss for a year compared to 6-month gain of -19.43%.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
The stock witnessed a -24.90% loss in the last 1 month and extending the period to 3 months gives it a -26.91%, and is -6.04% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.39% over the week and 3.53% over the month.
Allscripts Healthcare Solutions Inc. (MDRX) has around 8000 employees, a market worth around $1.50B and $837.20M in sales. Current P/E ratio is 14.23 and Fwd P/E is 14.62. Profit margin for the company is 7.20%. Distance from 52-week low is -0.89% and -42.41% from its 52-week high. The company has generated returns on investments over the last 12 months (3.30%).
Allscripts Healthcare Solutions Inc. (MDRX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Allscripts Healthcare Solutions Inc. (MDRX) is a “Overweight”. 8 analysts offering their recommendations for the stock have an average rating of 2.30, where 3 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.
Allscripts Healthcare Solutions Inc. is expected to release its quarterly report on 05/04/2023.The EPS is expected to grow by 216.00% this year
Allscripts Healthcare Solutions Inc. (MDRX) Top Institutional Holders
The shares outstanding are 110.21M, and float is at 106.64M with Short Float at 9.13%.
Allscripts Healthcare Solutions Inc. (MDRX) Insider Activity
A total of 6 insider transactions have happened at Allscripts Healthcare Solutions Inc. (MDRX) in the last six months, with sales accounting for 6 and purchases happening 0 times. The most recent transaction is an insider sale by Poulton Richard J., the company’s CEO. SEC filings show that Poulton Richard J. sold 10,000 shares of the company’s common stock on Feb 16 at a price of $17.33 per share for a total of $0.17 million. Following the sale, the insider now owns 0.67 million shares.
Allscripts Healthcare Solutions Inc. disclosed in a document filed with the SEC on Feb 15 that Poulton Richard J. (CEO) sold a total of 10,000 shares of the company’s common stock. The trade occurred on Feb 15 and was made at $17.38 per share for $0.17 million. Following the transaction, the insider now directly holds 0.68 million shares of the MDRX stock.
Still, SEC filings show that on Dec 12, Vakharia Tejal (SVP General Counsel) disposed off 8,642 shares at an average price of $18.42 for $0.16 million. The insider now directly holds 222,604 shares of Allscripts Healthcare Solutions Inc. (MDRX).
Allscripts Healthcare Solutions Inc. (MDRX): Who are the competitors?
The company’s main competitors (and peers) include Streamline Health Solutions Inc. (STRM) that is trading 33.83% up over the past 12 months and McKesson Corporation (MCK) that is 17.73% higher over the same period. General Electric Company (GE) is 24.42% up on the 1-year trading charts.
